Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.

@article{Moatti2000AdherenceTH,
  title={Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.},
  author={Jean Paul Moatti and M P Carrieri and Bruno Spire and J. A. Gastaut and Jill Patrice Cassuto and Jacques Moreau},
  journal={AIDS},
  year={2000},
  volume={14 2},
  pages={151-5}
}
OBJECTIVES To assess adherence to highly active antiretroviral therapies (HAART) in a cohort of French patients infected by HIV through injection drug use (IDU), and the impact on adherence of buprenorphine ambulatory drug maintenance treatment (DMT) which has been widely introduced since 1996. DESIGN Adherence assessment at first visit after initiation of HAART in the MANIF2000 cohort study. METHODS Patient's face-to-face and self-administered questionnaires. Univariate and logistic… CONTINUE READING